AI company Sensyne Health plc has appointed Dr David Ruau as chief scientific officer, a newly created role, with effect from 1 September 2021. He will lead…
Sensyne announces new chief scientific officer
About LaingBuisson
LaingBuisson has been serving clients for over 30 years with insights, analysis and data on market structures, policy and strategy across healthcare, social care and education.
Contact us: [email protected]
Follow LaingBuisson
©2024 All rights reserved LaingBuisson 
